Ophthalmo-Septonex (Carbaethopendecinium Bromide)

Carbaethopendecinium Bromide is a quaternary ammonium antiseptic that disrupts bacterial cell membranes, leading to leakage of cellular contents and rapid bacterial death. Its broad‑spectrum activity targets both Gram‑positive and Gram‑negative organisms on the eye.

The dosing regimen for Ophthalmo‑Septonex is determined by the prescribing clinician based on the specific indication, severity of infection, and patient factors. Healthcare professionals set the appropriate frequency and duration of administration.

Use of Ophthalmo‑Septonex during pregnancy or lactation should only be considered if the potential benefit justifies any possible risk to the fetus or infant. The decision rests with the treating physician after evaluating the clinical situation.

To order Ophthalmo‑Septonex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ophthalmo‑Septonex offers a quaternary ammonium antiseptic with broad‑spectrum activity, providing rapid bacterial kill and good ocular tolerance. Compared with povidone‑iodine or chlorhexidine formulations, it is formulated specifically for ophthalmic use, minimizing irritation while maintaining antimicrobial efficacy.

Ophthalmo‑Septonex should be stored at temperatures below 25 °C, in its original packaging, protected from light and moisture. Avoid freezing and keep the container tightly sealed to maintain sterility.

The product is applied topically to the eye as an ophthalmic solution. The prescribed number of drops is instilled into the conjunctival sac of the affected eye(s) according to the clinician’s instructions, typically using a sterile dropper.

Serious risks, though rare, include allergic conjunctivitis, corneal epithelial toxicity, and severe ocular inflammation. Patients should be monitored for signs of hypersensitivity or worsening ocular condition and discontinue use if serious reactions occur.

Individuals with known hypersensitivity to Carbaethopendecinium Bromide or other quaternary ammonium compounds should avoid using Ophthalmo‑Septonex. It is also contraindicated in eyes with active corneal ulcers or severe epithelial defects unless directed by a specialist.